Skip to content

Clinical trials

Phase 1 Pulmonary Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Phase 1 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20101
20111
20132
20151
20181
20212
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cedars-Sinai Medical Center1
Celgene1
Gilead Sciences1
Hoffmann-La Roche1
Joshua M Hare1
Kyntra Bio1
Massachusetts General Hospital1
NYU Langone Health1
Suneet Agarwal1
Thomas Hope1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis12
Idiopathic Pulmonary Fibrosis5
Fibrosis2
Idiopathic Interstitial Pneumonias2
Lung Diseases2
Lung Diseases, Interstitial2
Alveolitis, Extrinsic Allergic1
Bone Marrow Failure Disorders1
Cystic Fibrosis1
Dyskeratosis Congenita1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.